EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudie

Supramastoid Fascia as an Autologous Donor Site Alternative for Moderate Dorsal Augmentation: A Multicenter Prospective Study

Yang Hu, Chengwu Zhang, Yonggan Niu, Xiangyu Chen, Ziqiang Zhou, Songrui Zhang, Sijia Zhou, Jianda Zhou, Ping Li

Aesthetic Surgery Journal · 2025

DOI: 10.1093/asj/sjaf248 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Aesthetic Surgery Journal, 2025. Verfasst von Yang Hu und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Fascia, Rhinoplasty, Transplant Donor Site. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autologous fascia has been widely applied in rhinoplasty; yet, prospective data on the supramastoid donor site remain scarce. This region provides a dense, pliable fascial layer with concealed scarring, potentially suitable for moderate nasal dorsal augmentation.

Objectives

To prospectively evaluate the clinical outcomes, long-term stability, and patient satisfaction of supramastoid fascia as an autologous graft material for dorsal augmentation.

Methods

This multicenter observational study enrolled patients between June 2022 and April 2024. Dorsal projection and fascial thickness were measured by 3D photogrammetry and 15-MHz ultrasound at 1, 6, 12, 24, and 36 months, with patient satisfaction assessed using the FACE-Q Rhinoplasty Module. Longitudinal changes were analyzed using repeated-measures ANOVA and linear mixed-effects models.

Results

Among 73 patients, 67 (91.8%) completed ≥12 months of follow-up; 65% were observed beyond 24 months and 19% to ≥36 months. Dorsal height increased significantly at 1 month and remained stable through 36 months (P > .05 after 12 months). Mean resorption rate was 8.6 ± 3.7% at 12 months and 9.4 ± 4.1% at 36 months. FACE-Q satisfaction scores remained >80 across all domains without late decline. No graft displacement, irregularity, or donor-site morbidity was observed.

Conclusions

The supramastoid fascia is a practical, minimally invasive autologous donor-site alternative for moderate dorsal augmentation, showing stable projection and high satisfaction through 36 months. Longer follow-up and multi-ethnic cohorts are warranted. Level of Evidence: 2 (Therapeutic)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FasciaRhinoplastyTransplant Donor SiteAdultFemaleHumansMaleMiddle AgedYoung AdultFollow-Up StudiesPatient SatisfactionProspective StudiesTransplantation, AutologousTreatment Outcome

Zitieren

APA

Hu, Y., Zhang, C., Niu, Y., Chen, X., Zhou, Z., Zhang, S., Zhou, S., Zhou, J., & Li, P. (2025). Supramastoid Fascia as an Autologous Donor Site Alternative for Moderate Dorsal Augmentation: A Multicenter Prospective Study. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjaf248

Vancouver

Hu Y, Zhang C, Niu Y, Chen X, Zhou Z, Zhang S, et al. Supramastoid Fascia as an Autologous Donor Site Alternative for Moderate Dorsal Augmentation: A Multicenter Prospective Study. Aesthetic Surgery Journal. 2025. doi:10.1093/asj/sjaf248

BibTeX
@article{Hu2025,
  author = {Hu, Yang and Zhang, Chengwu and Niu, Yonggan and Chen, Xiangyu and Zhou, Ziqiang and Zhang, Songrui and Zhou, Sijia and Zhou, Jianda and Li, Ping},
  title = {Supramastoid Fascia as an Autologous Donor Site Alternative for Moderate Dorsal Augmentation: A Multicenter Prospective Study},
  journal = {Aesthetic Surgery Journal},
  year = {2025},
  doi = {10.1093/asj/sjaf248}
}
Kostenlos starten →